Prosecution Insights
Last updated: April 19, 2026

Klotho Therapeutics Inc.

2 pending office actions

Portfolio Summary

2
Total Pending OAs
1
Final Rejections
1
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18015041 WATER SOLUBLE PRODRUGS OF PTBA FOR USE IN HDAC INHIBITION AND ENHANCING RENAL RECOVERY FOLLOWING ACUTE KIDNEY INJURY KIFLE, BRUCK 1624 Non-Final OA Jan 06, 2023
18015040 NOVEL COMPOUNDS AND METHODS FOR INCREASING KLOTHO GENE EXPRESSION VAJDA, KRISTIN ANN 1622 Final Rejection Jan 06, 2023

Managing Klotho Therapeutics Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month